Patent References 3803120 3891696 InventorsAssigneeApplicationNo. 569009 filed on 04/17/1975US Classes:560/251, Plural nitrogens in alcohol moiety530/324, 25 or more amino acid residues in defined sequence530/325, 24 amino acid residues in defined sequence530/326, 15 to 23 amino acid residues in defined sequence530/327, 11 to 14 amino acid residues in defined sequence530/328, 8 to 10 amino acid residues in defined sequence530/329, 6 to 7 amino acid residues in defined sequence530/330, 4 to 5 amino acid residues in defined sequence530/331, Tripeptides, e.g., tripeptide thyroliberin (TRH), melanostatin (MIF), etc.560/40, Phenylalanines562/446, Di-oxy phenyl alanines930/290Polyamino acid or polypeptide with an uninterrupted series of peptide repeating unitsExaminersPrimary: Gotts, LewisAssistant: Suyat, Reginald J. Attorney, Agent or FirmAbstractThere is provided, novel, transient pro-drug forms of L-DOPA (3,4-dihydroxy-L-phenylalanine), having the formula: ##STR1## wherein n represents an integer of from 2 to 50 with respect to formula (V-A), and wherein n represents an integer of from 1 to 50 with respect to formula (V-B);R represents a hydrogen atom, an acyl group, ##STR2## --CO-pyridyl, or --CO--R3, wherein R3 is the residue of any N,N-C1 -C2 dialkylamino acid or a C4 -C6 cycloalkylamino acid; R1 represents --OH, --O-lower alkyl, --O-benzyl, or a naturally occurring protein amino acid; and R2 represents ##STR3## --CO-pyridyl, a naturally occurring protein amino acid, 3',4'-L-diacyloxy phenylalanine, or --CO-R3.These compounds are all useful in the treatment of Parkinson's Disease. |
| ||||||||||||||